Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from the National Institute for Health and Care Excellence

Type 2 diabetes patients set for major shake-up in care

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a one-size-fits-all approach.

The Independent UK

Heart patients to be offered rehab online under new draft guidance

The six platforms have been conditionally recommended in new draft guidance from the National Institute for Health and Care Excellence.

Evening Standard

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Breakthrough drug that slows onset of type 1 diabetes set for UK release

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

The Independent UK

Warning issued to patients who stop using weight-loss jabs

Health experts are calling for further help for those on the injections

The Independent UK

Weight-loss jabs linked to hundreds of cases of life-threatening illness and 10 deaths

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK’s medicines regulator reveal

The Independent UK

Weight-loss drugs among breakthrough trials offering ‘hope’ for dementia prevention

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Voices: The near-2.5m Brits with ADHD are not making it up

COMMENT: As the NHS releases the first official figures about the number of Britons with ADHD, Kat Brown writes that the way we disparage what we don't understand reflects both on our own fear and lack of literacy – and the irresponsible way we stigmatise wider disabled society

The Independent UK

Endometriosis: daily pill to manage symptoms will soon be available on the NHS – here’s how linzagolix works

A daily pill to treat endometriosis has just been recommended by the National Institute for Health and Care Excellence (Nice). Once available on the NHS, linzagolix will provide a new treatment option for those who have been unable to manage the condition using other standard treatments.

The Conversation

New treatment for advanced blood cancer recommended for use on NHS

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.

Evening Standard

Women with menopause symptoms ‘should be offered HRT as first treatment’

The National Institute for Health and Care Excellence announced the changes

The Independent UK

Hundreds of blood cancer patients to benefit from new treatment

Elranatamab, an injection that treats myeloma, has been recommended for NHS use by the National Institute for Health and Care Excellence.

Evening Standard

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

The Independent UK

Struggling to get a child ADHD diagnosis? New NHS test expected to be speedier for millions of kids

The National Institute for Health and Care Excellence believes the test will speed up getting diagnoses for children as young as six

GoodToKnow

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Landmark sickle cell drug axed by regulators

Exclusive: Crizanlizumab was hailed as first new drug to be introduced in over 20 years for people living with sickle cell disease

Chronicle Live

How the new 'game-changing' weight loss drug works, who is eligible and when it will be available in UK

The National Institute for Health and Care Excellence gave approval for the use of appetite suppressant Wegovy (semaglutide) earlier this year - here are more details about it

Nottingham Post

Eamonn Holmes among 28 million suffering in 'silent epidemic' pain

The National Institute for Health and Care Excellence (NICE), The British Pain Society (BPS) have dubbed the illness a silent epidemic

The Independent UK

Thousands could get new pill to combat migraines on the NHS

The National Institute for Health and Care Excellence’s draft guidance published on Wednesday recommended the drug Rimegepant as an option

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Thousands of people could get new pill to combat migraines

The National Institute for Health and Care Excellence’s draft guidance published on Wednesday recommended the drug Rimegepant as an option.

The Guardian - UK

Male GPs in England less likely to refer patients for IVF, report finds

Survey shows wide discrepancies between Nice guidelines and GP responses and ‘utter confusion’ on eligibility criteria

The Independent UK

Genetic testing recommended for most common type of stroke

The National Institute for Health and Care Excellence has issued new guidance on drugs which can prevent future attacks.

The Guardian - UK

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

the National Institute for Health and Care Excellence

22 stories

the National Pharmacy Association

19 stories

the Royal College of Physicians

15 stories

ABPI

13 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.